Who Owns the Intellectual Property Rights Associated with Hydroxychloroquine?

By: Jordan Meggison-Decker | 04.20.2020

  As efforts to discover new treatments for COVID-19 continue, attention has been brought upon an old drug, hydroxychloroquine.  The renewed attention follows several statements by the Federal Drug Administration (“FDA”) and issuance of an Emergency Use Authorization for use of hydroxychloroquine from the national stockpile for treatment of COVID-19. Hydroxychloroquine is a “modern” synthetic Read…

COVID-19 Will Spawn a Slew of New Patent Filings

By: David Breiner | 03.26.2020

  Currently, we are inundated with information about COVID-19, which is short for coronavirus disease 2019. Coronaviruses are relatively large spherical viruses having projections extending from their outer surface. Once attached to a host cell, the host cell cleaves, allowing the genetic material of the virus to enter the host cell. Once inside, the genetic Read…